Morgan Stanley lowered the firm’s price target on Avantor (AVTR) to $27 from $28 and keeps an Overweight rating on the shares. Avantor had an “in line print” as return to growth in LSS / Bioprocessing recovery was offset by U.S. semis weakness, the analyst tells investors in a post-earnings note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: